论文信息 - Hydrochloroquine retinopathy: characteristic presentation with review of screening - 字舞流文

Hydrochloroquine retinopathy: characteristic presentation with review of screening

H. Walia | Sandeep S. Walia | C. Stelton | Daniel B. Connors

[1] J. Bargman,et al. The role of antimalarial agents in the treatment of SLE and lupus nephritis , 2011, Nature Reviews Nephrology.

[2] Michael S. Lee. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy , 2011 .

[3] M. Michaelides,et al. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. , 2011, Archives of ophthalmology.

[4] M. Marmor,et al. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus , 2010, Arthritis care & research.

[5] M. Easterbrook. Ocular effects and safety of antimalarial agents. , 1988, The American journal of medicine.

[6] E. Dubois,et al. Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. , 1967, American journal of ophthalmology.

[7] J. Vander. Retinal Toxicity Associated With Hydroxychloroquine and Chloroquine: Risk Factors, Screening, and Progression Despite Cessation of Therapy , 2011 .

[8] Haitao Li,et al. The clinical applications of multifocal electroretinography: a systematic review. , 2007, Survey of ophthalmology.